Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

15.01
+0.21001.42%
Post-market: 15.00-0.0115-0.08%19:32 EDT
Volume:3.09M
Turnover:46.19M
Market Cap:30.86B
PE:12.89
High:15.15
Open:14.76
Low:14.68
Close:14.80
52wk High:15.37
52wk Low:7.80
Shares:2.06B
Float Shares:233.42M
Volume Ratio:0.93
T/O Rate:1.32%
Dividend:0.99
Dividend Rate:6.60%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:11.80%
ROA:5.66%
PB:1.53
PE(LYR):12.89

Loading ...

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

GlobeNewswire
·
Mar 26

Shrinking EUA supply puts EU ETS under policy strain

Fastmarkets
·
Mar 26

Ecopetrol Says No Violations, Contract Breaches to Date Related to Formal Charges Against President Ricardo Roa

MT Newswires Live
·
Mar 26

Ecopetrol says ‘committed’ to safeguarding interests of company, shareholders

TIPRANKS
·
Mar 25

EC urged to stop Fifa’s ‘aggressive and exploitative’ World Cup ticket prices

cityam
·
Mar 24

Ecopetrol price target raised to $13 from $8.70 at Goldman Sachs

TIPRANKS
·
Mar 23

Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

Dow Jones
·
Mar 20

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

GlobeNewswire
·
Mar 20

Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 19

S’pore private residential market to remain resilient despite Mideast tensions: HSBC

Jovi Ho
·
Mar 19

Press Release: Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

Dow Jones
·
Mar 18

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire
·
Mar 18

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Mar 17

Sector Update: Energy Stocks Higher in Afternoon Trading

MT Newswires Live
·
Mar 13

Ecopetrol President Ricardo Roa Indicted for Alleged Influence Peddling

MT Newswires Live
·
Mar 12

Auto a key market to drive steel decarbonization: SteelWatch

Fastmarkets
·
Mar 12

Press Release: Ecopetrol's 2025 Earnings Distribution Proposal

Dow Jones
·
Mar 05

Ecopetrol options imply 2.6% move in share price post-earnings

TIPRANKS
·
Mar 05

Ecopetrol SA expected to post earnings of 34 cents a share - Earnings Preview

Reuters
·
Mar 03

Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity

GlobeNewswire
·
Mar 02